The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary results from the Female Asian Nonsmoker Screening Study (FANSS).
 
Elaine Shum
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Boehringer Ingelheim; Genentech; Janssen
Research Funding - Delfi Diagnostics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Nektar
 
Wenyuan Li
No Relationships to Disclose
 
Lecia V. Sequist
Consulting or Advisory Role - AstraZeneca; Genentech/Roche; Takeda
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Delfi Diagnostics (Inst); Novartis (Inst)
 
Sai-Hong Ignatius Ou
Stock and Other Ownership Interests - Elevation Oncology; Turning Point Therapeutics
Honoraria - ARIAD/Takeda; BeiGene; Caris Life Sciences; Daiichi Sankyo; Dava Oncology; Johnson & Johnson/Janssen; Lilly; Pfizer
Consulting or Advisory Role - BeiGene; Daiichi Sankyo; Elevation Oncology; Janssen; Lilly; Pfizer; Takeda
Speakers' Bureau - Caris Life Sciences
Research Funding - ARIAD (Inst); AstraZeneca (Inst); AstraZeneca/MedImmune (Inst); Janssen (Inst); Mirati Therapeutics (Inst); Pfizer (Inst); Revolution Medicines (Inst); Roche Pharma AG (Inst)
 
Judith D. Goldberg
Consulting or Advisory Role - Tizona Therapeutics, Inc.
Research Funding - assorted companies- see below
 
Abraham Chachoua
No Relationships to Disclose
 
Kwok-Kin Wong
Stock and Other Ownership Interests - Array BioPharma; Bluebird Bio; G1 Therapeutics
Honoraria - AstraZeneca; Bristol-Myers Squibb; Genocea Biosciences; Janssen Oncology; Merck; Mirati Therapeutics; Novartis; Pfizer
Research Funding - Blueprint Medicines (Inst); BridgeBio Pharma (Inst); Bristol Myers Squibb Foundation (Inst); Delfi Diagnostics (Inst); Janssen Oncology (Inst); Janssen Oncology (Inst); Mirati Therapeutics (Inst); Pfizer (Inst); Takeda (Inst); Tango Therapeutics (Inst)
Travel, Accommodations, Expenses - Takeda